Stocks and InvestingStocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022

Salveen Richter Maintained (TSHA) at Strong Buy with Decreased Target to $16 on, May 24th, 2022


Published on 2024-10-27 21:16:41 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Decreased Target from $27 to $16 on, May 24th, 2022.

Salveen has made no other calls on TSHA in the last 4 months.



There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 0 agree with Salveen's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Salveen


  • Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $20 on, Tuesday, May 17th, 2022
  • Joon Lee of "Truist Securities" Maintained at Strong Buy with Decreased Target to $35 on, Friday, April 1st, 2022
  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $36 on, Friday, April 1st, 2022
  • Jack Allen of "Baird" Initiated at Buy and Held Target at $26 on, Wednesday, March 9th, 2022
  • Yanan Zhu of "Wells Fargo" Initiated at Buy and Held Target at $25 on, Tuesday, March 1st, 2022